Articles published in Journal of Stem Cell Research & Therapy have been cited by esteemed scholars and scientists all around the world. Journal of Stem Cell Research & Therapy has got h-index 33, which means every article in Journal of Stem Cell Research & Therapy has got 33 average citations.
Following are the list of articles that have cited the articles published in Journal of Stem Cell Research & Therapy.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total published articles |
22 | 58 | 59 | 65 | 23 | 13 | 36 | 34 | 49 | 63 | 101 | 62 | 44 | 26 |
Research, Review articles and Editorials |
2 | 4 | 1 | 2 | 12 | 12 | 29 | 28 | 44 | 56 | 80 | 48 | 12 | 19 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
20 | 54 | 58 | 63 | 11 | 1 | 7 | 6 | 5 | 7 | 21 | 14 | 32 | 6 |
Conference proceedings |
0 | 40 | 12 | 37 | 0 | 0 | 145 | 138 | 95 | 63 | 154 | 72 | 54 | 0 |
Citations received as per Google Scholar, other indexing platforms and portals |
522 | 678 | 761 | 838 | 697 | 626 | 613 | 599 | 538 | 478 | 262 | 142 | 31 | 69 |
Journal total citations count | 6793 |
Journal impact factor | 1.64 |
Journal 5 years impact factor | 1.70 |
Journal cite score | 11.56 |
Journal h-index | 33 |
Rare diseases in healthcare priority setting: should rarity matter?
Primary liver cancer: surveillance, diagnosis and treatment
Cost-utility analysis of imaging for surveillance and diagnosis of hepatocellular carcinoma
Assessing the Value of Therapies in Alzheimer’s Disease
QUESTIONING THE QALY: A CLOSER LOOK AT THE QUALITY-ADJUSTED LIFE-YEAR
Broadening the Measurement and Valuation of Health and Quality of Life
QALYs and cost-effectiveness thresholds: critical reflections
Medicaid Formulary Decisions and the Institute for Clinical and Economic Review: Abandoning Pseudoscience in Imaginary Pharmaceutical Pricing Claims
A guide to cost-effective management of leg ulcers
Pediatric Vaccines and Cost-Effectiveness Thresholds: How Much is Too Much to Pay for Prevention?
The application of multi-criteria decision analysis to inform in resource allocation
QALYs and medical costs saved from prevention of a cancer: Analysis of nation-wide real-world data of Taiwan with lifetime horizon
About the Institute for Patient Access
Comparing the Fiscal Consequences of Controlled and Uncontrolled Osteoarthritis Pain Applying a UK Public Economic Perspective
The application of multi-criteria decision analysis to inform in resource allocation
Kann Rationierung fair sein? Ethische Überlegungen zur Ressourcenbegrenzung im Gesundheitswesen
Preference-based measurement of mobility-related quality of life: developing the MobQoL-7D health state classification system
Operationalization of concepts of health and disability
Minimizing Population Health Loss in Times of Scarce Surgical Capacity
The application of multi-criteria decision analysis to inform in resource allocation